The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Mutations in hepatocyte nuclear factor-1β and their related phenotypes
Open accessAbstract
Background: Hepatocyte nuclear factor-1 beta (HNF-1β) is a widely distributed transcription factor which plays a critical role in embryonic development of the kidney, pancreas, liver, and Mullerian duct. Thirty HNF-1β mutations have been reported in patients with renal cysts and other renal developmental disorders, young-onset diabetes, pancreatic atrophy, abnormal liver function tests, and genital tract abnormalities. Methods: We sequenced the HNF-1β gene in 160 unrelated subjects with renal disease, 40% of whom had a personal/family history of diabetes. Results: Twenty three different heterozygous HNF-1β mutations were identified in 23/160 subjects (14%), including 10 novel mutations (V61G, V110G, S148L, K156E, Q176X, R276Q, S281fsinsC, R295P, H324fsdelCA, Q470X). Seven (30%) cases were proven to be due to de novo mutations. Renal cysts were found in 19/23 (83%) patients (four with glomerulocystic kidney disease, GCKD) and diabetes in 11/23 (48%, while three other families had a family history of diabetes. Only 26% of families met diagnostic criteria for maturity-onset diabetes of the young (MODY) but 39% had renal cysts and diabetes (RCAD). We found no clear genotype/phenotype relationships. Conclusion: We report the largest series to date of HNF-1β mutations and confirm HNF-1β mutations as an important cause of renal disease. Despite the original description of HNF-1β as a MODY gene, a personal/family history of diabetes is often absent and the most common clinical manifestation is renal cysts. Molecular genetic testing for HNF-1β mutations should be considered in patients with unexplained renal cysts (including GCKD), especially when associated with diabetes, early-onset gout, or uterine abnormalities.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mutations in the hepatocyte nuclear factor-1α gene in maturity-onset diabetes of the young (MODY3)
Yamagata, K., Oda, N., Kaisaki, P. J., Menzel, S., Furuta, H., Vaxillaire, M., Southam, L., Cox, R. D., Lathrop, G. M., Boriraj, V. V., et al. (1996) · Nature · doi:10.1038/384455a0 · Cited by 1,614
Self-citationMutation in hepatocyte nuclear factor–1β gene (TCF2) associated with MODY
Horikawa, Y., Iwasaki, N., Hara, M., Furuta, H., Hinokio, Y., Cockburn, B. N., Lindner, T., Yamagata, K., Ogata, M., Tomonaga, O., et al. (1997) · Nature Genetics · doi:10.1038/ng1297-384 · Cited by 880
Lindner, T. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.11.2001 · Cited by 367
Bile system morphogenesis defects and liver dysfunction upon targeted deletion of HNF1β
Coffinier, C., Gresh, L., Fiette, L., Tronche, F., Schütz, G., Babinet, C., Pontoglio, M., Yaniv, M., & Barra, J. (2002) · Development · doi:10.1242/dev.129.8.1829 · Cited by 358
Clinical Spectrum Associated with Hepatocyte Nuclear Factor-1β Mutations
Bellanné-Chantelot, C., Chauveau, D., Gautier, J.-F., Dubois-Laforgue, D., Clauin, S., Beaufils, S., Wilhelm, J.-M., Boitard, C., Noël, L.-H., Velho, G., et al. (2004) · Annals of Internal Medicine · doi:10.7326/0003-4819-140-7-200404060-00009 · Cited by 358
Variant Hepatocyte Nuclear Factor 1 is required for visceral endoderm specification
Barbacci, E., Reber, M., Ott, M.-O., Breillat, C., Huetz, F., & Cereghini, S. (1999) · Development · doi:10.1242/dev.126.21.4795 · Cited by 293
Bingham, C., Bulman, M. P., Ellard, S., Allen, L. I. S., Lipkin, G. W., Hoff, W. G. V., Woolf, A. S., Rizzoni, G., Novelli, G., Nicholls, A. J., et al. (2001) · The American Journal of Human Genetics · doi:10.1086/316945 · Cited by 287
Self-citationvHNF1 is a homeoprotein that activates transcription and forms heterodimers with HNF1.
Rey-Campos, J., Chouard, T., Yaniv, M., & Cereghini, S. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb07665.x · Cited by 278
Essential role for the homeoprotein vHNF1/HNF1β in visceral endoderm differentiation
Coffinier, C., Thépot, D., Babinet, C., Yaniv, M., & Barra, J. (1999) · Development · doi:10.1242/dev.126.21.4785 · Cited by 239
Frayling, T. M., Bulman, M. P., Ellard, S., Appleton, M., Dronsfield, M. J., Mackie, A. D. R., Baird, J. D., Kaisaki, P. J., Yamagata, K., Bell, G. I., et al. (1997) · Diabetes · doi:10.2337/diab.46.4.720 · Cited by 231
Self-citationExpression of the vHNF1/HNF1β homeoprotein gene during mouse organogenesis
Coffinier, C., Barra, J., Babinet, C., & Yaniv, M. (1999) · Mechanisms of Development · doi:10.1016/s0925-4773(99)00221-x · Cited by 216
Bingham, C., Ellard, S., Allen, L., Bulman, M., Shepherd, M., Frayling, T., Berry, P. J., Clark, P. M., Lindner, T., Bell, G. I., et al. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.057003898.x · Cited by 179
Self-citationBingham, C., Ellard, S., van't Hoff, W. G., Simmonds, H. A., Marinaki, A. M., Badman, M. K., Winocour, P. H., Stride, A., Lockwood, C. R., Nicholls, A. J., et al. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00903.x · Cited by 161
Self-citationMaestro, M. A., Boj, S. F., Luco, R. F., Pierreux, C. E., Cabedo, J., Servitja, J., German, M. S., Rousseau, G. G., Lemaigre, F. P., & Ferrer, J. P. (2003) · Human Molecular Genetics · doi:10.1093/hmg/ddg355 · Cited by 157
Bingham, C., Ellard, S., Cole, T. R. P., Jones, K. E., Allen, L. I. S., Goodship, J. A., Goodship, T. H. J., Bakalinova-Pugh, D., Russell, G. I., Woolf, A. S., et al. (2002) · Kidney International · doi:10.1046/j.1523-1755.2002.00272.x · Cited by 156
Self-citationNishigori, H., Yamada, S., Kohama, T., Tomura, H., Sho, K., Horikawa, Y., Bell, G. I., Takeuchi, T., & Takeda, J. (1998) · Diabetes · doi:10.2337/diab.47.8.1354 · Cited by 152
Contrasting Diabetes Phenotypes Associated With Hepatocyte Nuclear Factor-1α and -1β Mutations
Pearson, E. R., Badman, M. K., Lockwood, C. R., CLARK, P. M. S., Ellard, S., Bingham, C., & Hattersley, A. T. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1102 · Cited by 147
Self-citationYorifuji, T., Kurokawa, K., Mamada, M., Imai, T., Kawai, M., Nishi, Y., Shishido, S., Hasegawa, Y., & Nakahata, T. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031828 · Cited by 136
Kolatsi‐Joannou, M., Bingham, C., Ellard, S., Bulman, M. P., Allen, L. I. S., Hattersley, A. T., & Woolf, A. S. (2001) · Journal of the American Society of Nephrology · doi:10.1681/asn.v12102175 · Cited by 135
Self-citationHNF1 β/TCF2 mutations impair transactivation potential through altered co-regulator recruitment
Barbacci, E., Chalkiadaki, A., Masdeu, C., Haumaître, C., Lokmane, L., Loirat, C., Cloarec, S., Talianidis, I., Bellanné‐Chantelot, C., & Cereghini, S. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh338 · Cited by 100
Clinical spectrum associated with hepatocyte nuclear factor-1bêta mutations.
Bellanne-Chantelot, Chauveau, Gautier, & Dubois-Laforgue (2004) · Annals of Internal Medicine · Cited by 95
Wang, L., Coffinier, C., Thomas, M. K., Gresh, L., Eddu, G., Manor, T., Levitsky, L. L., Yaniv, M., & Rhoads, D. B. (2004) · Endocrinology · doi:10.1210/en.2004-0281 · Cited by 78
Nishigori, H., Yamada, S., Kohama, T., et al. (1998) · Diabetes · doi:10.2337/diabetes.47.8.1354 · Cited by 76
Wild, W., von Strandmann, E. P., Nastos, A., Senkel, S., Lingott, A., Bulman, M. P., Bingham, C., Ellard, S., Hattersley, A. T., & Ryffel, G. U. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.080010897 · Cited by 73
Self-citationFuruta, H., Furuta, M., Sanke, T., Ekawa, K., Hanabusa, T., Nishi, M., Sasaki, H., & Nanjo, K. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.8.8776 · Cited by 61
Montoli, A., Colussi, G., Massa, O., Caccia, R., Rizzoni, G., Civati, G., & Barbetti, F. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.34538 · Cited by 57
Harries, L. W., Bingham, C., Bellanné‐Chantelot, C., Hattersley, A. T., & Ellard, S. (2005) · Human Genetics · doi:10.1007/s00439-005-0023-y · Cited by 53
Self-citationThomas, H. (2004) · Nucleic Acids Research · doi:10.1093/nar/gnh144 · Cited by 51
Variant Hepatocyte Nuclear Factor 1 expression in the mouse genital tract
Reber, M., & Cereghini, S. (2001) · Mechanisms of Development · doi:10.1016/s0925-4773(00)00493-7 · Cited by 46
Kitanaka, S., Miki, Y., Hayashi, Y., & Igarashi, T. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031308 · Cited by 44
Iwasaki, N., Babazono, T., Tomonaga, O., Ogata, M., Yokokawa, H., & Iwamoto, Y. (2001) · Diabetologia · doi:10.1007/s001250051590 · Cited by 22
Cited by
Pathophysiology of diabetes: An overview
Sameer, A., Banday, M., & Nissar, S. (2020) · Avicenna Journal of Medicine · doi:10.4103/ajm.ajm_53_20 · Cited by 756
Gudmundsson, J., Sulem, P., Steinthorsdottir, V., Bergthorsson, J. T., Thorleifsson, G., Manolescu, A., Rafnar, T., Gudbjartsson, D., Agnarsson, B. A., Baker, A., et al. (2007) · Nature Genetics · doi:10.1038/ng2062 · Cited by 723
Clinical implications of a molecular genetic classification of monogenic β-cell diabetes
Murphy, R., Ellard, S., & Hattersley, A. T. (2008) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0778 · Cited by 502
“Diabetes diagnosed before 6 months of age Diabetes diagnosed before 6 months of age is likely to be one of the monogenic forms of neonatal diabetes and not autoimmune type 1 diabetes”
BackgroundSelf-citationBest practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the young
Ellard, S., Bellanné-Chantelot, C., Hattersley, A. T., & European Molecular Genetics Quality Network (EMQN) MODY group (2008) · Diabetologia · doi:10.1007/s00125-008-0942-y · Cited by 433
Self-citationHNF1B-associated renal and extra-renal disease—an expanding clinical spectrum
Clissold, R. L., Hamilton, A. J., Hattersley, A. T., Ellard, S., & Bingham, C. (2015) · Nature Reviews Nephrology · doi:10.1038/nrneph.2014.232 · Cited by 352
Self-citation
Metadata
- Authors
- Edghill, E. L., Bingham, C., Ellard, S., & Hattersley, A. T.
- Venue
- Journal of Medical Genetics
- Publisher
- BMJ
- Published
- 2005-06-01
- Volume
- 43
- Issue
- 1
- Pages
- 84-90
- ISSN
- 0022-2593 (ISSN-L)
- 1468-6244
- OpenAlex
- W2168831278
- Cited by
- 344
- References
- 31
- FWCI
- 9.41
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.